Additionally, miR-193b-3p dramatically decreased the levels of phospho-STAT3 (Tyr705), phospho-STAT3 (Ser727), and phospho-NF-κB p65 (Ser311) (Figs. 2 and S3), indicating that miR-193b-3p not only reduces the production of inflammatory factors but also blocks the STAT3 and NF-κB pathways, which are two important pathways that affect the inflammatory response in psoriasis pathogenesis [36, 37]. Here, NFKB1 is linked to psoriasis.